- Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine.
- Samusieva A, Serga S, Klymenko S, Rybchenko L, Klimuk B, Zakhartseva L, Gorovenko N, Lobanova O, Rossokha Z, Fishchuk L, Levkovich N, Medvedieva N, Popova O, Cheshuk V, Inomistova M, Khranovska N, Skachkova O, Michailovich Y, Ponomarova O, Kozeretska I
- Breast Cancer Res Treat. 2022 Aug 5. doi: 10.1007/s10549-022-06692-3. Epub ahead of print.
- PMID: 35930098
- PubMed abstract
- Source abstract
- Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".
- Bhatt A, Bhandoria G, Kepenekian V, Bakrin N, Glehen O.
- Int J Cancer. 2022 Aug 5. doi: 10.1002/ijc.34220. Epub ahead of print.
- PMID: 35857415
- PubMed abstract
- Comment. Letter.
Reply, Letter:
Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".
- PMID: 35857410
- PubMed abstract
- Source abstract
Original research:
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer - results from the phase III OVHIPEC trial.
- PMID: 35583992
- PubMed abstract
- Source abstract
- Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants.
- Brewer T, Yehia L, Bazeley P, Eng C.
- Am J Hum Genet. 2022 Aug 4;109(8):1520-1533. doi: 10.1016/j.ajhg.2022.07.005. Epub 2022 Aug 4.
Research news: PTEN Mutation Syndrome Leads to Breast Cancers With Distinct Molecular Alterations. (GenomeWeb)
- Eligibility, uptake and response to germline genetic testing in women with DCIS.
- Turza L, Lovejoy LA, Turner CE, Shriver CD, Ellsworth RE.
- Front Oncol. 2022 Aug 4;12:918757. doi: 10.3389/fonc.2022.918757.
- What happens after menopause? (WHAM): A prospective controlled study of symptom profiles up to 12 months after pre-menopausal risk-reducing salpingo-oophorectomy.
- Moss KM, Mishra GD, Krejany EO, Hickey M.
- Gynecol Oncol. 2022 Aug 3:S0090-8258(22)00513-3. doi: 10.1016/j.ygyno.2022.07.029. Epub ahead of print.
- Therapie des metastasierten Pankreaskarzinoms [Treatment of metastatic pancreatic cancer].
- Heinemann V, Boeck S, Westphalen CB.
- Inn Med (Heidelb). 2022 Aug;63(8):851-862. German. doi: 10.1007/s00108-022-01334-8. Epub 2022 Jul 6.
- PMID: 35925070
- PubMed abstract
- Source abstract
- Review. [Article in German]
- Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants.
- Edaily S, Abdel-Razeq H.
- Onco Targets Ther. 2022 Jul 27;15:815-826. doi: 10.2147/OTT.S369844.
- PMID: 35923470
- PubMed abstract
- Review
- Free PMC article
- Free Full Text